Q1 2013 StemCells, Inc. Earnings Conference Call|
2013 Regen Med Investor
April 17, 2013 New York, NY
Martin McGlynn, President & CEO, StemCells, Inc.
Dr. Stephen Huhn, MD, VP and Head of CNS Program, StemCells, Inc.
Q4 and Year 2012 StemCells, Inc. Earnings Conference Call|
March 21, 2013, 1:30 p.m. PDT
BIO CEO & Investor Conference|
Martin McGlynn, President and CEO, StemCells, Inc.
February 11-12, 2013, New York, NY
Click here for webcast